Bravecto Plus RSS Authorised This medicine is authorised for use in the European Union fluralaner / moxidectin Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Bravecto Plus Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Bravecto Plus : EPAR - Medicine overview English (EN) (81.94 KB - PDF)First published: 07/06/2018 Last updated: 28/06/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View español (ES) (81.97 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View čeština (CS) (93.99 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View dansk (DA) (83.34 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View français (FR) (82.44 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View íslenska (IS) (83.29 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View italiano (IT) (82.29 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View magyar (HU) (94.15 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Malti (MT) (95.95 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View norsk (NO) (82 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View polski (PL) (95.62 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View português (PT) (83.01 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View română (RO) (94.17 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Suomi (FI) (81.54 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View svenska (SV) (82.05 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Product information Bravecto Plus : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 07/06/2018 Last updated: 28/06/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View español (ES) (81.51 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View čeština (CS) (92.48 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View dansk (DA) (82.05 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View français (FR) (81.63 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View íslenska (IS) (81.52 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View italiano (IT) (81.76 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View magyar (HU) (92.76 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Malti (MT) (93.86 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View norsk (NO) (81.52 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View polski (PL) (93.22 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View português (PT) (82.53 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View română (RO) (91.73 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Suomi (FI) (81.11 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View svenska (SV) (81.47 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Bravecto Plus : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 07/06/2018 Last updated: 28/06/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View español (ES) (81.97 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View čeština (CS) (93.99 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View dansk (DA) (83.34 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View français (FR) (82.44 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View íslenska (IS) (83.29 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View italiano (IT) (82.29 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View magyar (HU) (94.15 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Malti (MT) (95.95 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View norsk (NO) (82 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View polski (PL) (95.62 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View português (PT) (83.01 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View română (RO) (94.17 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Suomi (FI) (81.54 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View svenska (SV) (82.05 KB - PDF) First published: 07/06/2018 Last updated: 28/06/2024 View Product details Name of medicine Bravecto Plus Active substance fluralanermoxidectin International non-proprietary name (INN) or common name fluralanermoxidectin Pharmacotherapeutic groupAntiparasitic products, insecticides and repellentsEndectocidesMilbemycins Authorisation details EMA product number EMEA/V/C/004440 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Bravecto Plus : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 08/01/2019 Last updated: 28/06/2024 View CVMP post-authorisation summary of positive opinion for Bravecto Plus (VRA)Adopted Reference Number: EMA/CVMP/51467/2023 English (EN) (127.1 KB - PDF)First published: 17/02/2023 View Bravecto Plus-H-C-4440-II-0006: EPAR - Assessment Report- VariationAdopted English (EN) (81.49 KB - PDF)First published: 12/02/2020 Last updated: 28/06/2024 View CVMP post-authorisation summary of positive opinion Bravecto Plus (II-0006)Adopted Reference Number: EMA/CVMP/599149/2019 English (EN) (128.85 KB - PDF)First published: 08/11/2019 View Bravecto Plus-H-C-4440-II-0003: EPAR - Assessment Report- VariationAdopted English (EN) (81.49 KB - PDF)First published: 23/07/2019 Last updated: 28/06/2024 View CVMP post-authorisation summary of positive opinion for Bravecto PlusAdopted Reference Number: EMA/CVMP/256330/2019 English (EN) (68.79 KB - PDF)First published: 24/05/2019 View Initial marketing authorisation documents Bravecto Plus : EPAR - Public assessment reportAdopted English (EN) (81.49 KB - PDF)First published: 07/06/2018 Last updated: 28/06/2024 View CVMP summary of positive opinion for Bravecto PlusAdopted Reference Number: EMA/CVMP/35302/2018 English (EN) (71 KB - PDF)First published: 16/03/2018 Last updated: 16/03/2018 View News on Bravecto Plus Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 202317/02/2023 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 202108/10/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 July 202116/07/2021 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 February 202021/02/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 3-5 December 201906/12/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 November 201908/11/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 September 201913/09/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 21-22 May 201924/05/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 March 201816/03/2018 Topics Medicines This page was last updated on 28/06/2024 Share this page